Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06098729 · ClinicalTrials.gov registry record · NA

Digital Exercise for Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes

A NA study of Type 1 Diabetes and Pancreatitis, sponsored by Yale University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06098729 is a NA study of Type 1 Diabetes and Pancreatitis that has completed, run by Yale University. The registered enrollment target is 24 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06098729, a NA study of Type 1 Diabetes and Pancreatitis, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently.

Interventions

  • BEHAVIORAL Digital Exercise

Study Locations (1)

Connecticut

  • Yale School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2023-11-02
Est. Completion 2024-10-25
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT06098729

The ClinicalTrials.gov registry entry for NCT06098729 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Digital Exercise is the first listed.

NCT06098729 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06098729 about?

NCT06098729 is a clinical study titled "Digital Exercise for Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes". The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This research will develop a mobile application ...

What is the current status of trial NCT06098729?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-11-02. Estimated completion is 2024-10-25.

What conditions does trial NCT06098729 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Pancreatitis, Latent Autoimmune Diabetes in Adults.

What interventions are being tested in trial NCT06098729?

The interventions under investigation include: Digital Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT06098729?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06098729 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.